Not so long ago, not only was the patient not informed (s)he had cancer (the family was called aside) but the news of the disease was also received as a death sentence. Not today, where many types of cancer have become chronic health conditions rather than critical ones. Two upcoming webinars announced on sciencemag will announce new approaches.
The first is Cancer Immunology: Charting the course forward for immune-profiling on April 1, in which the speakers will be Dr. Bernard A. Fox, from Providence Portland Medical Center, Portland, Oregon, USA and Clifford Hoyt, of PerkinElmer Inc., Hopkinton, MA, USA.
The webinar well focus on how numerous factors interplay making each case of cancer unique for each individual, as cells react in different ways, interacting with others in the same body. The webinar will point out that these interactions can ensure the survival of cells and will point out that even cells affected by cancer are influenced by the medium in which they are inserted.
Sciencemag's current issue states that "associations of cancer cells with the normal peritumoral microenvironment can profoundly impact tumor growth and development".
The webinar will also show how new technologies and approaches to cancer treatment allow effects on the interaction of cells with cancerous cells/tumors and associations between tumor cells and the body's immune system.
Biomarkers are beginning to be used for targeted drug therapy in which the tumor is targeted and destroyed while the tissue surrounding it remains intact. The webinar will focus on how improved patient stratification can be brought to the fore to enhance clinical trials and new treatment protocols.
The main points raided will therefore be immune profiling using FFPE tissue sections, the development of biomarkers and the latest technologies and approaches for IHC methods and measuring cellular interaction.
The second webinar on April 16 also available on Sciencemag online is "New technologies for translational research: Applying high-content screening in cancer research and personalized medicine", speakers Dr. Rune Linding, University of Copenhagen, Denmark and Dr. Stefan Kubicek, Austrian Academy of Sciences, Vienna, Austria.
This webinar will also focus on novel techniques and therapies, following up how bioscreening methods have been developing, and recent developments in imaging technology have aided high-content screening (HCS).
This webinar will focus on HCS technologies and increase awareness of deep learning in cancer research
Timothy Bancroft-Hinchey
Pravda.Ru
(timothy.hinchey@gmail.com)
*Timothy Bancroft-Hinchey has worked as a correspondent, journalist, deputy editor, editor, chief editor, director, project manager, executive director, partner and owner of printed and online daily, weekly, monthly and yearly publications, TV stations and media groups printed, aired and distributed in Angola, Brazil, Cape Verde, East Timor, Guinea-Bissau, Portugal, Mozambique and São Tomé and Principe Isles; the Russian Foreign Ministry publication Dialog and the Cuban Foreign Ministry Official Publications. He has spent the last two decades in humanitarian projects, connecting communities, working to document and catalog disappearing languages, cultures, traditions, working to network with the LGBT communities helping to set up shelters for abused or frightened victims and as Media Partner with UN Women, working to foster the UN Women project to fight against gender violence and to strive for an end to sexism, racism and homophobia. He is also a Media Partner of Humane Society International, fighting for animal rights.